Irvine-based AcuFocus Inc. has been selected as a finalist in the 2012 Medical Design Excellence Awards (MDEA) for its KAMRA corneal inlay, a permanent implant that reverses the effects of presbyopia, a condition that results in near-sight vision loss, usually as a result of aging.
The MDEA honors innovative advancements in the medical device industry, recognizing companies whose research, design and engineering has transformed healthcare products and medical practices. Companies are judged by a third-party panel based on their products’ use of materials, features that improve healthcare delivery and benefit patients, and on their ability to overcome challenges presented in the development of their devices.
When inserted into the cornea during laser surgery, the KAMRA implant increases the eye’s depth of focus to restore vision. Although the implant, which is smaller than a contact lens, is available overseas, it is still an investigational product in the United States and is not yet available on the domestic market.
“As a company, we’re excited to be recognized by the MDEA for our ongoing accomplishments in the medical device industry,” said AcuFocus CEO Ed Peterson. “The KAMRA inlay is the product of boundless hard work and innovation by our entire team which includes clinical input from surgeons around the world. In light of the ongoing acceptance of the inlay globally, with over 10,000 patients implanted today and high patient satisfaction, to also be chosen as a finalist for this esteemed award is a great honor.”
AcuFocus is among three finalists in the Implant and Tissue Replacement Products category. The winners will be announced at an awards ceremony in Philadelphia on May 23.
Irvine-based AcuFocus launches research study for corneal inlay
AcuFocus raises $65 million in funding
Monarch HealthCare launches a new mobile app to assist plan members